PK assessors variability [Bioanalytics]

posted by Obinoscopy  – USA, 2020-07-17 23:48 (275 d 00:57 ago) – Posting: # 21735
Views: 2,800

Hi Ohlbe,

» In Europe: add the between-country variability. In the US: possibly a between-review-division variability ?


I wonder the study design we can use to measure these variabilities...especially the variability within the USFDA.

But this is sad...I had thought standardization and uniformity of regulatory review methods should be one of the foundation of regulatory science.


Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Monday 00:45 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz